Clinical Trial Update: Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of tofacitinib on coagulation, platelet function, and thromboembolic events in patients with ulcerative colitis an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolism
• Ulcerative Colitis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Ulcerative Colitis, Thromboembolism | Phase 4 | Status: RECRUITING